CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients

References

• Zhu J, Tan Z, Hollis-Hansen K, et al. Epidemiological trends in colorectal cancer in china: an ecological study. Dig Dis Sci. 2017;62(1):235–243. doi:10.1007/s10620-016-4362-4
   PubMed Web of Science ®Google Scholar
• Xu M, Guo X, Wang RD, et al. Long non-coding RNA HANR as a biomarker for the diagnosis and prognosis of colorectal cancer. Medicine. 2020;99(7):e19066. doi:10.1097/MD.0000000000019066
   PubMed Web of Science ®Google Scholar
• Solaki M, Ewald JC. Fueling the cycle: cDKs in carbon and energy metabolism. Front Cell Dev Biol. 2018;6:93. doi:10.3389/fcell.2018.00093
   PubMed Web of Science ®Google Scholar
• Cicenas J, Valius M. The CDK inhibitors in cancer research and therapy. J Cancer Res Clin Oncol. 2011;137(10):1409–1418. doi:10.1007/s00432-011-1039-4
   PubMed Web of Science ®Google Scholar
• Somarelli JA, Roghani RS, Moghaddam AS, et al. A precision medicine drug discovery pipeline identifies combined CDK2 and 9 inhibition as a novel therapeutic strategy in colorectal cancer. Mol Cancer Ther. 2020;19(12):2516–2527. doi:10.1158/1535-7163.MCT-20-0454
   PubMed Web of Science ®Google Scholar
• Du Q, Guo X, Wang M, et al. The application and prospect of CDK4/6 inhibitors in malignant solid tumors. J Hematol Oncol. 2020;13(1):41. doi:10.1186/s13045-020-00880-8
   PubMed Web of Science ®Google Scholar
• Ruiz de Porras V, Bystrup S, Cabrero-de Las Heras S, et al. Tumor expression of cyclin-dependent kinase 5 (Cdk5) Is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients. Cancers. 2019;11(10):1540. doi:10.3390/cancers11101540
   PubMed Web of Science ®Google Scholar
• Sánchez-Martínez C, Lallena MJ, Sanfeliciano SG, et al. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: recent advances (2015–2019). Bioorg Med Chem Lett. 2019;29(20):126637. doi:10.1016/j.bmcl.2019.126637
   PubMed Web of Science ®Google Scholar
• Whittaker SR, Mallinger A, Workman P, et al. Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacol Ther. 2017;173:83–105. doi:10.1016/j.pharmthera.2017.02.008
   PubMed Web of Science ®Google Scholar
• Marak BN, Dowarah J, Khiangte L, et al. A comprehensive insight on the recent development of cyclic dependent kinase inhibitors as anticancer agents. Eur J Med Chem. 2020;203:112571. doi:10.1016/j.ejmech.2020.112571
   PubMed Web of Science ®Google Scholar
• Zhuang K, Zhang J, Xiong M, et al. CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. Cell Death Dis. 2016;7:e2415. doi:10.1038/cddis.2016.333
   PubMed Web of Science ®Google Scholar
• Dale T, Clarke PA, Esdar C, et al. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol. 2015;11:973–980. doi:10.1038/nchembio.1952
   PubMed Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big bioMedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Ghandi M, Huang FW, Jané-Valbuena J, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569(7757):503–508. doi:10.1038/s41586-019-1186-3
   PubMed Web of Science ®Google Scholar
• Zhou T, Cai Z, Ma N, et al. Novel ten-gene signature predicting prognosis in hepatocellular carcinoma. Front Cell Dev Biol. 2010;8:629. doi:10.3389/fcell.2020.00629
   Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/s1476-5586(04)80047-2
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Qin Y, Conley AP, Grimm EA, et al. tool for discovering drug sensitivity and gene expression associations in cancer cells. PLoS One. 2017;12(4):e0176763. doi:10.1371/journal.pone.0176763
   PubMed Web of Science ®Google Scholar
• Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847–2849. doi:10.1093/bioinformatics/btw313
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin E, Zhuang H, et al. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell Int. 2020;20:27. doi:10.1186/s12935-020-1113-6
   PubMed Web of Science ®Google Scholar
• Wu S, Lin W, Weng Y, et al. Characterization of hypoxia signature to evaluate the tumor immune microenvironment and predict prognosis in glioma. J Clin Oncol. 2020;38(15_suppl):e14534–e14534. doi:10.1200/JCO.2020.38.15
   Web of Science ®Google Scholar
• Xu F, Huang X, Li Y, et al. (2021). m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD. Mol Ther Nucleic Acids. 2021;(24):780–791. doi:10.1016/j.omtn.2021.04.003
   PubMedGoogle Scholar
• Xiong Y, Yuan L, Xiong J, et al. An outcome model for human bladder cancer: a comprehensive study based on weighted gene co-expression network analysis. J Cell Mol Med. 2020;24(3):2342–2355. doi:10.1111/jcmm.14918
   PubMed Web of Science ®Google Scholar
• Liu Z, Mi M, Li X, et al. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. J Cell Mol Med. 2020;24(21):12444–12456. doi:10.1111/jcmm.15762
   PubMed Web of Science ®Google Scholar
• Jeong SH, Kim RB, Park SY, et al. Nomogram for predicting gastric cancer recurrence using biomarker gene expression. Eur J Surg Oncol. 2020;46(1):195–201. doi:10.1016/j.ejso.2019.09.143
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Asplund A, Edqvist PH, Schwenk JM, et al. Antibodies for profiling the human proteome-the human protein atlas as a resource for cancer research. Proteomics. 2012;12(13):2067–2077. doi:10.1002/pmic.201100504
   PubMed Web of Science ®Google Scholar
• Jung G, Hernández-Illán E, Moreira L, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130. doi:10.1038/s41575-019-0230-y
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. Ca Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Costa NR, Gil da costa RM, Medeiros R. A viral map of gastrointestinal cancers. Life Sci. 2018;199:188–200. doi:10.1016/j.lfs.2018.02.025
   PubMed Web of Science ®Google Scholar
• Wang L, Xi Y, Sun C, et al. CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect. Exp Mol Pathol. 2017;102(2):181–190. doi:10.1016/j.yexmp.2017.01.008
   PubMed Web of Science ®Google Scholar
• Do PA, Lee CH. The role of CDK5 in tumours and tumour microenvironments. Cancers. 2020;13(1):101. doi:10.3390/cancers13010101
   PubMed Web of Science ®Google Scholar
• Chen R, Wang X, Zhou S, et al. LncRNA HOXA-AS2 promotes tumor progression by suppressing miR-567 expression in oral squamous cell carcinoma. Cancer Manag Res. 2021;13:5443–5455. doi:10.2147/CMAR.S305946
   PubMed Web of Science ®Google Scholar
• Zhu X, Yue L, Fan C, et al. Mechanism of Cdk5-synaptophysin-SNARE pathway in acute and chronic inflammatory pain. Am J Transl Res. 2021;13(3):1075–1084. PMID: 33841641.
   PubMed Web of Science ®Google Scholar
• Liang J, Chen M, Hughes D, et al. CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases. Cancer Res. 2018;78(23):6594–6606. doi:10.1158/0008-5472.CAN-18-1583
   PubMed Web of Science ®Google Scholar
• Hivroz C, Chemin K, Tourret M, et al. Crosstalk between T lymphocytes and dendritic cells. Crit Rev Immunol. 2012;32(2):139–155. doi:10.1615/critrevimmunol.v32.i2.30
   PubMed Web of Science ®Google Scholar